Análisis de la calidad de vida relacionada con la salud entre mujeres portadoras de hemofilia y no portadoras en una población del nororiente Colombiano

dc.contributor.advisorSossa Melo, Claudia Lucia
dc.contributor.advisorOchoa Vera, Miguel Enrique
dc.contributor.advisorPeña Castellanos, Angela María
dc.contributor.advisorLuna González, María Lucrecia
dc.contributor.apolounabSossa Melo, Claudia Lucia [claudia-lucia-sossa-melo]spa
dc.contributor.apolounabOchoa Vera, Miguel Enrique [miguel-enrique-ochoa-vera]spa
dc.contributor.apolounabLuna González, María Lucrecia [maría-lucrecia-luna-gonzález]spa
dc.contributor.authorManzano Di Zeo, Fabian Alberto
dc.contributor.cvlacSossa Melo, Claudia Lucia [0001425704]spa
dc.contributor.cvlacPeña Castellanos, Angela María [0001475570]spa
dc.contributor.cvlacOchoa Vera, Miguel Enrique [0000898465]spa
dc.contributor.cvlacLuna González, María Lucrecia [0001347422]spa
dc.contributor.googlescholarSossa Melo, Claudia Lucia [n1PL8iUAAAAJ]spa
dc.contributor.googlescholarLuna González, María Lucrecia [pLIVNZYAAAAJ]spa
dc.contributor.linkedinLuna González, María Lucrecia [maria-lucrecia-luna-gonzalez]spa
dc.contributor.orcidSossa Melo, Claudia Lucia [0000-0001-9876-222X]spa
dc.contributor.orcidOchoa Vera, Miguel Enrique [0000-0002-4552-3388]spa
dc.contributor.orcidLuna González, María Lucrecia [0000-0003-2846-6868]spa
dc.contributor.researchgateOchoa Vera, Miguel Enrique [Miguel_Ochoa7]spa
dc.contributor.researchgroupGrupo de Investigaciones Clínicasspa
dc.coverage.campusUNAB Campus Bucaramangaspa
dc.coverage.spatialFloridablanca (Santander,Colombia)spa
dc.coverage.temporalFebrero/2023 - Junio/2024spa
dc.date.accessioned2024-07-08T16:12:38Z
dc.date.available2024-07-08T16:12:38Z
dc.date.issued2024-07-03
dc.degree.nameEspecialista en Medicina Internaspa
dc.description.abstractIntroducción: Se estima que por cada hombre con hemofilia, existen 1.6 mujeres portadoras de hemofilia, es decir aproximadamente 1.8 millones a nivel mundial. A pesar de esto, la investigación clínica enfocada en este grupo es escasa. En la región nororiental de Colombia, se han realizado investigaciones centradas en hombres con hemofilia, sin embargo, existe una brecha en el conocimiento de posibles disparidades de salud dentro de sus familias. Este vacío señala una oportunidad para investigar la calidad de vida relacionada con la salud (CVRS) en mujeres portadoras de hemofilia, un área poco estudiada en la población colombiana. Objetivo: Examinar las dimensiones de la CVRS en mujeres portadoras obligadas de hemofilia y mujeres no portadoras en una población del Nororiente Colombiano. Métodos: Estudio observacional transversal incluyó 104 participantes: 52 mujeres portadoras obligadas de hemofilia, seleccionadas por patrón de herencia, quienes fueron emparejadas por edad y estrato socioeconómico con 52 mujeres no portadoras. Las participantes se convocaron mediante redes sociales durante los meses de marzo y abril de 2024. Los datos se recopilaron a través de entrevistas telefónicas y se empleó el cuestionario SF-36 como herramienta de evaluación de la CVRS. El estudio obtuvo aprobación del comité de ética institucional de la Universidad Autónoma de Bucaramanga (Acta N°248, de 15 de febrero del 2024) y se utilizó x2 para comparar los resultados entre los dos grupos. Resultados: Se observó una mediana de edad de 49 años, con la mayoría de la población en estrato socioeconómico bajo (59.6%), educación secundaria completa o estudios universitarios (37.5% y 27.9%, p<0.01). La mayoría de las mujeres portadoras obligadas de hemofilia se dedican a labores domésticas mientras que las no portadoras a labores no domesticas (66.7% y 58.8%, p<0.01). Se auto consideraron cuidadoras el 100% de las portadoras obligadas de hemofilia, mientras que ninguna de las no portadoras había asumido este rol. La carga de comorbilidad fue ausente tanto en mujeres portadoras obligadas de hemofilia como en mujeres no portadoras (75% y 76.2%, p=1), con la hipertensión arterial como la comorbilidad más frecuente en ambos grupos (9.6 y 15.4, p= 0.374). El análisis de la CVRS con el SF-36 mostró un alfa de Cronbach de 0.90 y sus dimensiones revelaron que las mujeres portadoras obligadas de hemofilia presentaron puntajes más bajos en función física (67.3% versus 98.0%, p < 0.01), salud general (50.0% versus 92.3%, p < 0.01), vitalidad (46.1% versus 90.4%, p < 0.01), función social (78.8% versus 96.1%, p = 0.015), rol emocional (40.4% versus 90.4%, p < 0.01) y salud mental (65.4% versus 82.7%, p = 0.04) en comparación con las mujeres no portadoras de hemofilia (Table 1). El grupo de portadoras obligadas de hemofilia registró una mayor percepción que su salud esta algo peor que el año anterior (32.7%) en comparación con las no portadoras (7.7%), p=0.008. Conclusión: Los hallazgos de este estudio resaltan la disparidad en la calidad de vida relacionada con la salud en mujeres portadoras obligadas de hemofilia y sugieren una percepción significativamente menor en comparación con las mujeres no portadoras. Estos resultados subrayan la necesidad de intervenciones específicas dirigidas a mejorar la calidad de vida de las mujeres afectadas por esta condición, acceso a atención médica especializada y servicios de apoyo psicosocial.spa
dc.description.abstractenglishAbstract: For every man with hemophilia, an estimated 1.6 women are carriers, approximately 1.8 million worldwide. Despite this, clinical research focused on this group is scarce. In northeastern Colombia, where research has been conducted on men with hemophilia, a valuable opportunity arises to address health-related quality of life (HRQoL) in female carriers of hemophilia. This assessment is crucial to understanding the impact of hemophilia on the overall well-being of these women. However, research on this topic in the Colombian population is limited. Objective: To examine the dimensions of HRQoL in obligate carriers and non-carriers of hemophilia in a northeastern Colombian population. Methods: An observational cross-sectional study included 104 participants: 52 obligate carriers, selected by inheritance pattern, who were matched by age and socioeconomic status with 52 non-carriers. Participant women were recruited through social media during March and April 2024. Data were collected through telephone interviews, and the SF-36 questionnaire was used as the HRQoL assessment tool. The study obtained approval from the Institutional Review Boad of the Universidad Autónoma de Bucaramanga (Minutes No. 248, February 15, 2024), and chi2 was used to compare results between the two groups. Results: A median age of 49 years was observed, with the majority of the population in the low socioeconomic stratum (59.6%), having completed secondary education or university studies (37.5% and 27.9%, p<0.01). Most obligate carriers were engaged in domestic work, while non-carriers were involved in non-domestic work (66.7% and 58.8%, p<0.01). All obligate carriers self-identified as caregivers, while none of the non-carriers had assumed this role. Comorbidity burden was absent in both obligate carriers and non-carriers (75% and 76.2%, p=1), with hypertension being the most frequent comorbidity in both groups (9.6 and 15.4, p= 0.374). Analysis of the HRQoL dimensions of the SF-36 revealed that non-carriers showed higher scores in physical function (98% versus 67.3%, p < 0.01), general health (92.3% versus 50%, p < 0.01), vitality (90.4% versus 46.1%, p < 0.01), social function (96.1% versus 78.8%, p = 0.015), emotional role (90.4% versus 40.4%, p < 0.01), and mental health (82.7% versus 65.4%, p = 0.04) compared to obligate carriers (see table). The obligate carriers group reported substantial difference of a higher perception that their health was somewhat worse than the previous year (32.7%) compared to non-carriers (7.7%), p=0.008. Conclusion: The findings of this study highlights the disparity in health-related quality of life in obligate carriers and suggest a significantly lower perception compared to non-carries. These results underscore the need for specific interventions aimed at improving the quality of life of women affected by hemophilia, their access to specialized medical care, and psychosocial support services.spa
dc.description.degreelevelEspecializaciónspa
dc.description.learningmodalityModalidad Presencialspa
dc.description.tableofcontentsPlanteamiento del Problema y Justificación.....................................................9 Marco Teórico ..................................................................................................... 13 Hemofilia y portadora de hemofilia ................................................................. 13 Calidad de Vida..................................................................................................... 24 Estado del Arte ..................................................................................................... 27 Pregunta de Investigación .................................................................................. 31 Hipótesis................................................................................................................. 31 Objetivos................................................................................................................. 32 Objetivo General ................................................................................................... 32 Objetivos Específicos............................................................................................. 32 Metodología............................................................................................................ 32 Tipo de Estudio ...................................................................................................... 32 Población ................................................................................................................. 32 Cálculo de la muestra ............................................................................................ 32 Criterios de Selección ............................................................................................ 33 Criterios de inclusión ............................................................................................. 33 Grupo de portadoras ............................................................................................. 33 Grupo de no portadoras ........................................................................................ 33 Criterios de exclusión ............................................................................................. 33 Tipo de Muestreo ..................................................................................................... 34 Procedimientos Para Recolección de Información y Cronograma ................... 34 Recolección de la información ............................................................................... 34 Variables .................................................................................................................... 35 Procesamiento y Control de Calidad de los Datos .............................................. 35 Definiciones del estudio .......................................................................................... 36 Plan de Análisis de Datos ........................................................................................ 37 Análisis univariado ................................................................................................... 37 Análisis bivariado ..................................................................................................... 37 Consideraciones éticas............................................................................................ 38 Resultados................................................................................................................. 39 Discusión .................................................................................................................. 54 Conclusión................................................................................................................ 57 Referencias .............................................................................................................. 59spa
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga - UNABspa
dc.identifier.reponamereponame:Repositorio Institucional UNABspa
dc.identifier.repourlrepourl:https://repository.unab.edu.cospa
dc.identifier.urihttp://hdl.handle.net/20.500.12749/25352
dc.language.isospaspa
dc.publisher.facultyFacultad Ciencias de la Saludspa
dc.publisher.grantorUniversidad Autónoma de Bucaramanga UNABspa
dc.publisher.programEspecialización en Medicina Internaspa
dc.publisher.programidEMIN-1050
dc.relation.referencesLévesque Boulevard R. Portadoras Y Mujeres Con Hemofilia. Federación Mundial de Hemofilia. Montréal, Canada; 2012. p. 3–21spa
dc.relation.referencesAy C, Thom K, Abu-hamdeh F, Horvath B, Quehenberger P, Male C, et al. Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women. Haemophilia. 2010 Jan;16(1):111–7spa
dc.relation.referencesIorio A, Stonebraker JS, Chambost H, Makris M, Coffin D, Herr C, et al. Establishing the prevalence and prevalence at birth of hemophilia in males a meta- analytic approach using national registries. Ann Intern Med. 2019 Oct 15;171(8):542–6spa
dc.relation.referencesKasper CK, Lin JC. How many carriers are there? Haemophilia. 2010 Sep 1;16(5):842spa
dc.relation.referencesFondo Colombiano de Enfermedades de Alto Costo. Situación de la hemofilia y otras coagulopatías en Colombia 2023. Bogotá, Colombia: Cuenta de Alto Costo [CAC]; 2024spa
dc.relation.referencesBlanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A. Definitions in hemophilia: Communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 2014 Nov 1;12(11):1935–9spa
dc.relation.referencesRemor E. Desarrollo de una Medida Específica para la Evaluación de la Calidad de Vida en Pacientes Adultos Viviendo con Hemofilia en América-Latina: el Hemolatin- QoL. Revista Interamericana de psicologia/Interamerican Journal of Psychology [Internet]. 2005;39(2):211–20. Available from: http://www.redalyc.org/articulo.oa?id=28439204spa
dc.relation.referencesOsooli M, Donfield SM, Carlsson KS, Baghaei F, Holmström M, Berntorp E, et al. Joint comorbidities among Swedish carriers of haemophilia: A register-based cohort study over 22 years. Haemophilia. 2019 Sep 14;25(5):845–50spa
dc.relation.referencesRodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. Journal of Thrombosis and Haemostasis. 2010 Sep;8(9):2063–5spa
dc.relation.referencesMackensen S V., Gringeri A. Quality of Life in Hemophilia. In: Handbook of Disease Burdens and Quality of Life Measures. Springer. New York, NY: Springer New York; 2010. p. 1895–920spa
dc.relation.referencesRemor E, Young NL, Von Mackensenà S, Lopatina EG. Disease-specific quality-of- life measurement tools for haemophilia patients. Haemophilia. 2004spa
dc.relation.referencesFischer K, Van Der Bom JG, Van Den Berg HM. Health-related quality of life as outcome parameter in haemophilia treatment. Haemophilia. 2003 May;9:75–82spa
dc.relation.referencesVelarde-Jurado E, Avila-Figueroa C. Evaluación de la calidad de vida [Internet]. Vol. 44, Salud Publica Mex. 2002. Available from: http://www.insp.mx/salud/index.htmlspa
dc.relation.referencesArango-Bernal YA. Significados de ser portadoras de hemofilia. Revista Ciencia y Cuidado. 2018 Jan 1;15(1):18spa
dc.relation.referencesSossa Melo CL, Wandurraga EA, Peña AM, Jiménez SI, Salazar LA, Ochoa ME, et al. Low bone mineral density and associated factors in patients with haemophilia in Colombia. Haemophilia. 2018 Jul;24(4):e222–9spa
dc.relation.referencesSrivastava A, Santagostino E, Dougall A, Kitchen S, Sutherland M, Pipe SW, et al. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia. 2020 Aug 1;26(S6):1–158spa
dc.relation.referencesKitchen S, McCraw A, Echenagucia M. Diagnosis of Hemophilia and Other Bleeding Disorders [Internet]. Second Edition. Montreal, Canada : World Federation of Hemophilia; 2010 [cited 2023 Apr 24]. Available from: https://www1.wfh.org/publications/files/pdf-1283.pdfspa
dc.relation.referencesMiller CH, Soucie JM, Byams VR, Payne AB, Sidonio RF, Buckner TW, et al. Women and girls with haemophilia receiving care at specialized haemophilia treatment centres in the United States. Haemophilia. 2021 Nov 1;27(6):1037–44spa
dc.relation.referencesFranchini M, Favaloro EJ, Lippi G. Mild hemophilia A. Vol. 8, Journal of Thrombosis and Haemostasis. 2010. p. 421–32spa
dc.relation.referencesVenkateswaran L, Wilimas JA, Jones DJ, Nuss R. Mild Hemophilia in Children. J Pediatr Hematol Oncol. 1998 Jan;20(1):32–5spa
dc.relation.referencesMauser Bunschoten EP, van Houwelingen JC, Sjamsoedin Visser EJ, van Dijken PJ, Kok AJ, Sixma JJ. Bleeding symptoms in carriers of hemophilia A and B. Thromb Haemost. 1988 Jun 16;59(3):349–52spa
dc.relation.referencesMerskey C. The occurrence of haemophilia in the human female. Q J Med. 1951 Jul;20(79):299–312spa
dc.relation.referencesThompson A, Bajaj SP, Chen SH, Macgillivray RTA. “Founder” effect in different families with haemophilia B mutation. The Lancet. 1990 Feb;335(8686):418spa
dc.relation.referencesCarcao M. The Diagnosis and Management of Congenital Hemophilia. Semin Thromb Hemost. 2012 Sep 25;38(07):727–34spa
dc.relation.referencesPotgieter JJ, Damgaard M, Hillarp A. One-stage vs. chromogenic assays in haemophilia A. Eur J Haematol. 2015 Feb;94:38–44spa
dc.relation.referencesBowyer AE, Van Veen JJ, Goodeve AC, Kitchen S, Makris M. Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A. Haematologica. 2013 Dec 1;98(12):1980–7spa
dc.relation.referencesLee CA, Kessler CM, Varon D, Martinowitz U, Heim M, GOODEVE AC. Advances in carrier detection in haemophilia. Haemophilia. 1998 Jul;4(4):358–64spa
dc.relation.referencesKlein HG, Aledort LM, Bouma BN, Hoyer LW, Zimmerman TS, DeMets DL. A Co- operative Study for the Detection of the Carrier State of Classic Hemophilia. New England Journal of Medicine. 1977 Apr 28;296(17):959–62spa
dc.relation.referencesKazazian HH. The molecular basis of hemophilia A and the present status of carrier and antenatal diagnosis of the disease. Thromb Haemost. 1993 Jul 1;70(1):60–2spa
dc.relation.referencesPoon MC, Chui DH, Patterson M, Starozik DM, Dimnik LS, Hoar DI. Hemophilia B (Christmas disease) variants and carrier detection analyzed by DNA probes. Journal of Clinical Investigation. 1987 Apr 1;79(4):1204–9spa
dc.relation.referencesvan Galen KPM, d’Oiron R, James P, Abdul-Kadir R, Kouides PA, Kulkarni R, et al. A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 2021 Aug 1;19(8):1883–7spa
dc.relation.referencesBorhany M, Fatima N, Abid M, Shamsi T, Othman M. Application of the ISTH bleeding score in hemophilia. Transfusion and Apheresis Science. 2018 Aug;57(4):556–60.spa
dc.relation.referencesJames PD, Mahlangu J, Bidlingmaier C, Mingot-Castellano ME, Chitlur M, Fogarty PF, et al. Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study. Haemophilia. 2016 Nov 21;22(6):912–8spa
dc.relation.referencesSrivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. Guidelines for the management of hemophilia. Haemophilia. 2013 Jan;19(1)spa
dc.relation.referencesGualtierotti R, Solimeno LP, Peyvandi F. Hemophilic arthropathy: Current knowledge and future perspectives. Journal of Thrombosis and Haemostasis. 2021 Sep;19(9):2112–21spa
dc.relation.referencesMannucci PM. Clinical Evaluation of Viral Safety of Coagulation Factor VIII and IX Concentrates. Vox Sang. 1993 May;64(4):197–203spa
dc.relation.referencesUrzúa M A, Caqueo-Urízar A. Calidad de vida: Una revisión teórica del concepto. Terapia psicológica. 2012 Apr;30(1):61–71spa
dc.relation.referencesSpilker B. Quality of Life and Pharmacoeconomics in Clinical Trials. Minneapolis, Minnesota; 1996spa
dc.relation.referencesSchwartzmann L. Calidad De Vida Relacionada Con La Salud: Aspectos Conceptuales. Ciencia y enfermería. 2003 Dec;9(2)spa
dc.relation.referencesBullinger M, Von Mackensen S, Fischer K, Khair K, Petersen C, Ravens-Sieberer U, et al. Pilot testing of the ‘Haemo-QoL’ quality of life questionnaire for haemophiliac children in six European countries. Haemophilia. 2002 Mar 23;8(s2):47–54spa
dc.relation.referencesArranz P, Remor E, Quintana M, Villar A, Díaz JL, Moreno M, et al. Development of a new disease-specific quality-of-life questionnaire to adults living with haemophilia. Haemophilia. 2004 Jul 28;10(4):376–82spa
dc.relation.referencesWare JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473–83spa
dc.relation.referencesThe EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy (New York). 1990 Dec;16(3):199–208spa
dc.relation.referencesWare JE. SF-36 Health Survey Update. Spine (Phila Pa 1976). 2000 Dec;25(24):3130–9.spa
dc.relation.referencesGarratt A. Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ. 2002 Jun 15;324(7351):1417–1417spa
dc.relation.referencesVilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana JM, et al. The Spanish version of the Short Form 36 Health Survey: a decade of experience and new developments. Gac Sanit. 2005;19(2):135–50spa
dc.relation.referencesAlonso J, Prieto L, Antó JM. The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results. Med Clin (Barc). 1995 May 27;104(20):771–6spa
dc.relation.referencesLugo LH, García HI, Gomez C. Confiabilidad del cuestionario de calidad de vida en salud SF-36 en Medellín, Colombia. Rev Fac Nac Salud Pública. 2006spa
dc.relation.referencesOlsson A, Hellgren M, Berntorp E, Ljung R, Baghaei F. Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B. Blood Coagulation & Fibrinolysis. 2014 Jul;25(5):471–5.spa
dc.relation.referencesGilbert L, Paroskie A, Gailani D, Debaun MR, Sidonio RF. Haemophilia A carriers experience reduced health-related quality of life. Haemophilia. 2015 Nov 30;21(6):761–5spa
dc.relation.referencesOlsson A, Hellgren M, Berntorp E, Baghaei F. Association between bleeding tendency and health-related quality of life in carriers of moderate and severe haemophilia. Haemophilia. 2015 Nov;21(6):742–6spa
dc.relation.referencesGrajales Toro S, Correa Silva JP, Cano Uribe S, Lopera García D, Pérez Orozco DJ, Álvarez Hernández K. Asociación entre calidad de vida relacionada con salud y factores sociodemográficos y antropométricos en una institución de salud de Medellín, Colombia. Revista Salud Bosque. 2020;10(1):41–51spa
dc.relation.referencesCastaño AF, Restrepo MJ, Salinas Durán F. Quality of life in a population with haemophilia: A cross-sectional study from a single haemophilia treatment centre. Revista Colombiana de Reumatologia. 2017 Jan 1;24(1):18–24spa
dc.relation.referencesCoppola A. Treatment of hemophilia: a review of current advances and ongoing issues. J Blood Med. 2010 Aug;183spa
dc.relation.referencesFischer K, Poonnoose P, Dunn AL, Babyn P, Manco-Johnson MJ, David JA, et al. Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective. Haemophilia. 2017 Jan 15;23(1):11–24spa
dc.relation.referencesCastaman G, Matino D. Hemophilia A and B: molecular and clinical similarities and differences. Haematologica. 2019 Sep;104(9):1702–9spa
dc.relation.referencesCasas C, Hernández S, Helena Solano M, Castiblanco R, Carrillo A. Experiencias de mujeres frente al cuidado de hijos diagnosticados con hemofilia. IATREIA. 2018;31(2):145–54spa
dc.relation.referencesHirayama AB, Silva AKC da, Rocha JS, Roberti M do RF. Prevalence of symptoms in hemophilia carriers in comparison with the general population: a systematic review. Hematol Transfus Cell Ther. 2019 Oct;41(4):349–55spa
dc.relation.referencesLópez-Arroyo JL, Pérez-Zúñiga JM, Merino-Pasaye LE, Saavedra-González A, Alcivar-Cedeño LM, Álvarez-Vera JL, et al. Consenso de hemofilia en México. Gac Med Mex. 2023 Mar 28;157(91)spa
dc.relation.referencesOsorio Guzmán M, Gutiérrez González G, Bazán Riverón G, Núñez Villegas N N, Fernández Castillo G J. Percepción de la calidad de vida relacionada con la salud y la depresión en pacientes con hemofilia. Revista Médica del Instituto Mexicano del Seguro Social . 2017;416–22spa
dc.relation.referencesVos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017 Sep;390(10100):1211–59spa
dc.relation.referencesKyu HH, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018 Nov;392(10159):1859–922spa
dc.relation.referencesFreedman VA, Spillman BC. Disability and Care Needs Among Older Americans. Milbank Q. 2014 Sep 9;92(3):509–41spa
dc.relation.referencesOrmel J, Petukhova M, Chatterji S, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, et al. Disability and treatment of specific mental and physical disorders across the world. British Journal of Psychiatry. 2008 May 2;192(5):368–75spa
dc.relation.uriapolohttps://apolo.unab.edu.co/en/persons/claudia-lucia-sossa-melospa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.rights.localAbierto (Texto Completo)spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.subject.keywordsInternal medicinespa
dc.subject.keywordsMedicinespa
dc.subject.keywordsMedical sciencesspa
dc.subject.keywordsHealth sciencesspa
dc.subject.keywordsQuality of lifespa
dc.subject.keywordsHemophiliaspa
dc.subject.keywordsFemalespa
dc.subject.keywordsLifestylesspa
dc.subject.keywordsBlood clotting disordersspa
dc.subject.keywordsBasic needsspa
dc.subject.keywordsIndicators of health conditionsspa
dc.subject.lembMedicina internaspa
dc.subject.lembMedicinaspa
dc.subject.lembCiencias médicasspa
dc.subject.lembEstilos de vidaspa
dc.subject.lembTrastornos de coagulación sanguíneaspa
dc.subject.lembNecesidades básicasspa
dc.subject.lembIndicadores de condiciones de saludspa
dc.subject.proposalCiencias de la saludspa
dc.subject.proposalCalidad de vidaspa
dc.subject.proposalHemofiliaspa
dc.subject.proposalMujerspa
dc.titleAnálisis de la calidad de vida relacionada con la salud entre mujeres portadoras de hemofilia y no portadoras en una población del nororiente Colombianospa
dc.title.translatedAnalysis of health-related quality of life among female carriers of hemophilia and non-carriers in a population of northeastern Colombiaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdcc
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.driverinfo:eu-repo/semantics/masterThesis
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.type.localTesisspa
dc.type.redcolhttp://purl.org/redcol/resource_type/TM

Archivos

Bloque original

Mostrando 1 - 2 de 2
Cargando...
Miniatura
Nombre:
Tesis_Fabian_Manzano_Dizeo.pdf
Tamaño:
3.69 MB
Formato:
Adobe Portable Document Format
Descripción:
Tesis
Cargando...
Miniatura
Nombre:
2024LicenciaFabian_Manzano.pdf
Tamaño:
133.47 KB
Formato:
Adobe Portable Document Format
Descripción:
Licencia

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
829 B
Formato:
Item-specific license agreed upon to submission
Descripción: